Impact of patient support programmes among patients with severe asthma treated with biological therapies: a systematic literature review and indirect treatment comparison

Autor: Azeem Majeed, Liam G Heaney, Zhiyi Lan, Tamsin Morris, Olivia Fulton, Adrian P J Rabe, Wei J Loke, Danuta Kielar, Vivian H Shih, Lynda Olinger, Mihaela G Musat, Sharada Harricharan

Publikováno v: BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)

Introduction Effective treatment of severe asthma requires patient adherence to inhaled and biological medications. Previous work has shown that patient support programmes (PSP) can improve adherence in patients with chronic diseases, but the impact

Externí odkaz: https://doaj.org/article/51f2b637096243fca634b9a2028a55b5

Persistence With Benralizumab Among Patients With Severe Eosinophilic Asthma Participating In The CONNECT 360 Patient Support Program

Autor: Adrian P.J. Rabe, Wei Loke, Tamsin Morris, Danuta Kielar, Vivian Shih, Olivia Fulton, Zhiyi Lan, Lynda Olinger, Mihaela Musat, Liam Heaney, Azeem Majeed

Publikováno v: Journal of Allergy and Clinical Immunology. 151:AB100

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86142f3a525d152b3408884b32656b7f
https://doi.org/10.1016/j.jaci.2022.12.321

EP1022: DISEASE BURDEN AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH EOSINOPHILIC GASTROINTESTINAL DISEASES (EGIDS) WITH OR WITHOUT OVERLAPPING EOSINOPHILIC DISEASES IN THE REAL WORLD INVESTIGATION OF EOSINOPHILIC-ASSOCIATED DISEASE OVERLAP (REVEAL) STUDY

Autor: Justin Kwiatek, Anamaria Brailean, Danuta Kielar, Rohit Katial, Xia Wang, Xiao Xu, Yong Jin Kim, Michael Stokes, Heide Stirnadel-Farrant

Publikováno v: Gastroenterology. 162:S-1033

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae319c5415ad7892db2a791bbe501ea1
https://doi.org/10.1016/s0016-5085(22)62459-4

Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries

Autor: Susanne Qvitzau, Andrew J. K. Östör, Alan Reynolds, Rose-Marie Lindkvist, Mats Ekelund, Per Larsson, Robert J. Moots, Pentti Järvinen, Anne G. R. Loft, Danuta Kielar

Publikováno v: Moots, R J, Ostor, A J K, Loft, A G R, Järvinen, P, Larsson, P, Ekelund, M, Reynolds, A, Kielar, D, Lindkvist, R-M & Qvitzau, S 2012, ' Reduction of direct and indirect costs in patients with AS receiving etanercept : results from an open-label 36-week extension of the ASCEND study in four European countries ', Rheumatology, vol. 51, no. 2, pp. 393-6 . https://doi.org/10.1093/rheumatology/ker404

OBJECTIVE: To characterize the impact of etanercept (ETN) in AS on cost, work productivity and quality of life (QoL).METHODS: A Phase 4, open-label, multi-centre (UK, Scandinavia) extension study in AS. Eligible subjects (n = 84) were treated for 36-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bf42659488942e087c8e5568d93c17
https://doi.org/10.1093/rheumatology/ker404

Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome

Autor: Charalampos Aslanidis, Danuta Kielar, Alfred Böttcher, Matthias Krüll, Mario Probst, Gerd Schmitz, Norbert Suttorp, Hajnalka Andrikovics, Marek Bodzioch, Katarzyna Lapicka-Bodzioch, Beata Kiec, Jaroslav A. Hubacek

Publikováno v: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1537:42-48

Familial high-density lipoprotein (HDL)-deficiency syndromes are caused by mutations of the ABCA1 gene, coding for the ATP-binding cassette transporter 1. We have developed a homogeneous assay based on 52 primer sets to amplify all 50 ABCA1 exons and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a51033a7ebcc65cabf8ebc107701cdf
https://doi.org/10.1016/s0925-4439(01)00053-9